Commonwealth Consolidated Regulations

THERAPEUTIC GOODS REGULATIONS 1990 - NOTES

Statutory Rules No. 394, 1990

made under the

Therapeutic Goods Act 1989

Compilation No. 124

Compilation date: 1 January 2025

Includes amendments: F2024L00689

About this compilation

This compilation

This is a compilation of the Therapeutic Goods Regulations 1990 that shows the text of the law as amended and in force on 1 January 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Self-repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

Part 1--Preliminary

1 Name of Regulations

2 Interpretation

2A Authorised officers

3 Corresponding State law

3AA Unacceptable presentation of therapeutic goods--prescribed class of medicine

3A Unacceptable presentations

3B Definitions relating to goods comprising etc. human cells and tissues

3C Classes of biologicals

Part 2--Advertisements

Division 1--Application of Part

4 Application of Part 2

4A Interpretation

Division 3--General provisions about advertising therapeutic goods

6AA Prescribed committees

6B Prohibited and required representations

7 Prescribed goods for advertising offence and civil penalty

7A Publisher exception for civil penalty provisions

Division 4--Generic information about ingredients or components of therapeutic goods

8 Compliance with the Code

Part 2A--Patient information

9A Information about certain therapeutic goods to be supplied

9B Information about therapeutic goods manufactured using human embryos

Part 2C--Australian Register of Therapeutic Goods

Division 2C.1--Registered and listed therapeutic goods

10 Goods to be included in parts of the Register (Act s 9A)

10AAA Variation of entries in Register--registered complementary medicines and registered OTC medicines

10AAB Variation of entries in Register--prescription medicines other than biological medicines

10AAC Variation of entries in Register--biological medicines

10AAD Variation of entries in Register--biologicals

10AA Prescribed requests for variations of entries in Register

10AB Change of person in whose name goods are listed or registered

10AC Change of name of person

10B Transfers within the Register

10C Re-assignment of registration or listing numbers

10D Notice of reassignment of registration or listing numbers

Division 2C.2--Medical devices included in the Register under Chapter 4

10E Goods to be included in part of the Register for medical devices (Act s 9A)

10F Change of person in relation to whom a medical device is included in the Register under Chapter 4 of the Act

10FA Change of name of person

Division 2C.3--Biologicals included in the Register

10G Goods to be included in the part of the Register for biologicals

10H Change of person for whom a biological is included in the Register under Part  3-2A of the Act

10HA Change of name of person

10I Re-assignment of biological numbers

10J Notice of reassignment of biological numbers

Part 2CA--Prohibition on import, export or manufacture of certain therapeutic goods--international agreements

Division 1--Prescribed international agreements

10JA Prescribed international agreements

Division 2--Prohibition on importation of mercury

10JB Importation of a therapeutic good that is mercury from a non-party to the Minamata Convention is prohibited unless approved by the Secretary before importation

Division 3--Prohibition on export of mercury

10JC Export of a therapeutic good that is mercury is prohibited unless approved by the Secretary before exportation

Division 4--Applications to import or export mercury

10JD Applications to import or export mercury

10JE When approval may be granted--importation

10JF When approval may be granted--export

Division 5--Mercury-added products

10JG Import, export and manufacture of therapeutic goods that are mercury-added products

10JH Manufacture of therapeutic goods containing mercury-added products

Part 2D--Provisional determinations for medicine

10K Applications for provisional determinations

10L Provisional determinations

Part 2E--Scientific advice about aspects of quality, safety or efficacy of medicine

10M Scientific advice about aspects of quality, safety or efficacy of medicine

Part 2F--Vaping goods

10N Commercial quantity of vaping goods

10P Unit of vaping goods

10Q Permitted quantity

Part 3--Registration, inclusion, listing and exemption of therapeutic goods

11 Characteristics that separate and distinguish certain medicines from other therapeutic goods

11A Characteristics that separate and distinguish certain biologicals from other biologicals

12 Exempt goods

12A Unapproved medicines and biological--exemption in life-threatening cases

12AAB Disposal of unused emergency goods and unused emergency biologicals

12AA Applications for special and experimental uses

12AB Goods imported etc for experimental uses

12AC Powers of authorised officers in relation to goods imported etc for experimental uses

12AD Use of goods for experimental purposes--specified conditions

12B Exemptions for certain uses--medicines

12BA Authorities for certain uses--therapeutic vaping substances that are not medicines

12C Exemptions for health practitioners--biologicals

15 Application of registration or listing number to goods

15AA Clinical trial registries

15A Conditions of registration and listing of medicines

16AA Information or documents that Secretary may require

16AB Specified periods

Part 3A--Applications for evaluation

Division 1--Preliminary

16A Interpretation--working day

Division 1A--Goods mentioned in Part 1 of Schedule 10

16C Applications for registration--notification of effectiveness and period for completing evaluations--general

16D Applications for variations--notification of effectiveness and period for deciding applications--general

16DA Conditions for periods for regulations 16C and 16D

16E Applications for variations--effect of failure to decide applications within specified period

16F Applications for variations--shorter period for deciding applications

16G Applications for registration--shorter period for completing evaluations

Division 2--Applications for evaluation of substances

16GA Evaluation other than evaluation under subsection 9D(1), (2) or (3) or section  25 of the Act

Division 3--Class 2, Class 3 and Class 4 biologicals

16GC Notification of preliminary assessment of applications and periods within which certain evaluations must be made

16GD Notification of effective request and period within which certain applications must be decided

16GE Failure to decide an application within specified time

16GF Evaluation, other than evaluation under subsection 9D(3A) or (3AA) or section  32DE of the Act

Division 4--Complementary medicines and certain other listed medicines

16GG Variation of certain entries in the Register--notification of effective requests and period within which decisions must be made

16GH Registration and listing of certain medicines--notification of preliminary assessment of applications and period within which evaluations must be completed

16GI Registration and listing of certain medicines--notification of preliminary assessment of applications and period within which decisions on recommendations must be made

16GIA Period for paying evaluation fee for application under subsection 26BD(1) of the Act

16GJ Determination of competent regulatory authority of a foreign country or foreign jurisdiction in relation to evaluation of applications

Part 3B--Designated orphan drugs

16H Application to designate medicine as orphan drug

16J Designation of medicine as orphan drug

16K Period during which designation is in force

16L Extension of designation

16M Revocation of designation

Part 3C--Therapeutic goods (priority applicant) determinations

16P Application of Part

16Q Application for therapeutic goods (priority applicant) determination

16R Making of therapeutic goods (priority applicant) determination

16S Period during which therapeutic goods (priority applicant) determination is in force

16T Revocation of therapeutic goods (priority applicant) determination

Part 3D--Biologicals (priority applicant) determinations

16U Application of Part

16V Application for biologicals (priority applicant) determination

16W Making of biologicals (priority applicant) determination

16X Period during which biologicals (priority applicant) determination is in force

16Y Revocation of biologicals (priority applicant) determination

Part 4--Licensing of manufacturers

17 Exempt goods for the purposes of subsection 34(1) of the Act

18 Exempt Persons

19 Requirements for licence holders

20 Conditions of licences

21 Persons having control of production etc to be named

22 Transfer of licences

Part 5--Examination, testing and analysis of goods

23 Interpretation

24 Authorised officer--powers and duties

25 Appointment of analysts and official analysts and powers of official analysts

26 Taking of samples for testing

26A Receiving samples for testing

27 Examination and testing of sample

28 Tests for determining conformity with a standard or compliance with essential principles

29 Certificate of responsible analyst

30 Review of results of examination and analysis

31 Payment for samples

32 Offences relating to analysis etc

33 Production of identity card

Part 5A--Exceptional release

33A Prescribed circumstances under which biologicals may be imported, exported or supplied

33B Conditions for supply of biologicals

33C Report on release of nonconforming biological

Part 6--Committees

Division 1A--Advisory Committee on Medicines

35 Establishment

35A Functions

35B Membership

Division 1D--Advisory Committee on Medical Devices

38 Establishment

38A Functions

38B Membership

Division 1E--Advisory Committee on Complementary Medicines

39 Establishment

39A Functions

39B Membership

Division 1EA--Advisory Committee on Biologicals

39C Establishment

39D Functions

39E Membership

Division 1EB--Advisory Committee on Vaccines

39F Establishment

39G Functions

39H Membership

Division 1F--General

40 Application of this Division

41 Appointment of members

41A Appointment of the chair

41B Resignation or vacancy

41C Termination of appointment

41D Leave of absence

41E Acting members

41F Committee procedures

41G Meetings

41H Presiding member

41I Quorum

41J Voting

42 Miscellaneous

Division 3A--Advisory Committee on Medicines Scheduling

Subdivision 3A.1--Preliminary

42ZCA Definitions for Division 3A

Subdivision 3A.2--Constitution of Committee

42ZCB Membership of Committee

42ZCC Committee members

42ZCD Appointed members

42ZCE Nominated members

42ZCF Appointment of the Chair and acting Chair

42ZCG Resignation or vacancy

42ZCH Termination of appointment

42ZCI Leave of absence

42ZCJ Acting members

Subdivision 3A.3--Committee meetings

42ZCK Committee meetings

42ZCL Meeting procedure

42ZCM Presiding member

42ZCN Quorum

42ZCO Voting

42ZCP Miscellaneous

Division 3B--Advisory Committee on Chemicals Scheduling

Subdivision 3B.1--Preliminary

42ZCQ Definitions for Division 3B

Subdivision 3B.2--Constitution of Committee

42ZCR Membership of Committee

42ZCS Committee members

42ZCT Appointed members

42ZCU Nominated members

42ZCV Appointment of the Chair and acting Chair

42ZCW Resignation or vacancy

42ZCX Termination of appointment

42ZCY Leave of absence

42ZCZ Acting members

Subdivision 3B.3--Committee meetings

42ZCZA Committee meetings

42ZCZB Meeting procedure--general

42ZCZC Presiding member

42ZCZD Quorum

42ZCZE Voting

42ZCZF Miscellaneous

Division 3C--Joint meetings

42ZCZG Joint meetings

42ZCZH Procedure for joint meetings

Division 3D--Procedure for amending the current Poisons Standard

Subdivision 3D.1--Preliminary

42ZCZI Definitions for Division 3D

Subdivision 3D.2--Procedure if proposed amendment referred to expert advisory committee

42ZCZJ Application

42ZCZK Proposed amendment to be referred to expert advisory committee

42ZCZL Consideration of public submissions

42ZCZM Committee to advise Secretary

42ZCZN Interim decision of Secretary

42ZCZO Secretary may make final decision if no interim decision required

42ZCZP Call for further submissions

42ZCZQ Reconsideration of interim decision

42ZCZR Final decision if there is an interim decision

42ZCZS Publication of final decision

Subdivision 3D.3--Procedure if proposed amendments not referred to expert advisory committee

42ZCZT Application

42ZCZU Final decision without interim decision

42ZCZV Interim decision required if Secretary decides not to amend as requested

42ZCZW Final decision if there is interim decision

42ZCZX Publication of final decision

Part 7--Charges for registration, listing and inclusion, licences, exemptions, costs and fees

Division 1--Charges for registration, listing and inclusion of therapeutic goods, exemptions and licences

Subdivision 1--Preliminary

43AAA Meaning of turnover and when turnover is of low value

Subdivision 1A--Time for payment of certain annual charges

43AAB Time for payment of certain annual charges

Subdivision 2--Exemption from liability to pay certain annual charges--therapeutic goods other than IVD devices

43AAAA Application

43AABA Purpose of this Subdivision

43AABB Exemption from liability to pay certain annual charges--2014-15 financial year--goods entered on Register on or after 1  May 2015 and on or before 30 June 2015

43AAC Exemption from liability to pay certain annual charges--2015-16 financial year

43AAD Exemption from liability to pay certain annual charges--financial years commencing on or after 1 July 2016

43AAE Exemption from liability to pay certain annual charges--late notice that turnover was of low value

43AAF Person may notify Secretary that turnover of goods for financial year will not be of low value

43AAG Secretary may notify person that annual charge is payable if turnover is not of low value

Subdivision 2A--Exemption from liability to pay annual charge--IVD devices

43AAGA Purpose of this Subdivision

43AAGB Exemption from liability to pay annual charge--2017-18 financial year

43AAGC Exemption from liability to pay annual charge--financial years commencing on or after 1 July 2018

43AAGD Exemption from liability to pay annual charge--late notice that turnover was of low value

43AAGE Person may notify Secretary that turnover of IVD device for financial year will not be of low value

43AAGF Secretary may notify person that annual charge is payable if turnover is not of low value

Subdivision 2B--Waiver of certain annual charges

43AAGG Purpose of Subdivision

43AAH Waiver of certain annual charges

Subdivision 3--Charges for licensing

43AAJ Licensing charge--reduction in certain circumstances

Division 2--Fees and costs

43 Fees

43A When is no application fee payable?

43AA Fee for evaluation--refund in certain circumstances

43AB Circumstances in which inspection fee covered by annual charge

43AC Refund of fees where no evaluation undertaken--registered OTC medicines

43ACA Refund of fees where no evaluation undertaken--certain registered and listed medicines

43AD Fee for therapeutic goods (priority applicant) determination application--refund in certain circumstances

43AE Fee for application for provisional determination relating to medicine--refund in certain circumstances

43AF Fee for request for variation of certain registered and listed medicines--refund in certain circumstances

44 Testing of samples--recovery of costs

45 Waiver or reduction of fees

45AA Payment of fees in instalments

Part 8--Miscellaneous

46AA Identity cards for authorised officers

46A Delegation under the Act

46B Protected persons

46 Release of information

47 Delegation--powers and functions under these Regulations

47A Delegation--powers under paragraphs 19(1)(a), 32CK(1)(d) and 41HB(1)(d) of the Act

47B Provision of information concerning medicines, biologicals and medical devices

47C Enforceable directions

48 Review of decisions

Part 9--Transitional

Division 1--Transitional provisions relating to the Therapeutic Goods Amendment Regulations 2010 (No. 1)

48A Definitions

48B Application of 2010 Amendment Regulations

Division 2--Transitional provisions relating to the Therapeutic Goods Amendment Regulation 2012 (No. 3)

49 Transitional

Division 3--Transitional provisions relating to the Therapeutic Goods Amendment (Registered Over the Counter Medicines) Regulation 2015

50 Application

Division 4--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (Charges Exemptions and Other Measures) Regulation 2016

51 Application

Division 5--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2017 Measures No. 1) Regulations  2017

52 Definitions

53 Transitional--continuing application of evaluation fees for variations of permissible ingredients determinations

54 Transitional--existing orphan drug designations

55 Transitional--pending orphan drug designation applications

56 Transitional--fee waivers in relation to certain designations

Division 6--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2017 Measures No. 2) Regulations  2017

57 Definitions

58 Application--statements in relation to unapproved medicines and biologicals

59 Transitional--approval of form for statements

Division 7--Application and saving provisions relating to the Therapeutic Goods Legislation Amendment (2018 Measures No. 1) Regulations  2018

60 Application provisions

61 Operation of Schedule 2--complementary medicines

62 Saving provision

Division 8--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (Exempt Devices and Goods) Regulations 2018

63 Application of amendments

Division 9--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2018 Measures No. 2) Regulations  2018

64 Definitions

65 Transitional provisions--exemptions from Parts 3-2 and 3 -2A of the Act

66 Transitional provisions--exemptions from Part 3-3 of the Act

Division 10--Application provisions relating to the Therapeutic Goods Legislation Amendment (2018 Measures No. 3) Regulations  2018

67 Application

Division 11--Application and transitional provisions relating to the Therapeutic Goods Amendment (Fees for Relisted Medicine) Regulations 2019

68 Application and transitional provisions

Division 12--Application and transitional provisions relating to the Therapeutic Goods Legislation Amendment (2019 Measures No. 1) Regulations  2019

Subdivision A--Definitions

69 Definitions

Subdivision B--Faecal microbiota transplant products

70 Faecal microbiota transplant products--Division 4 of Part  3-2A of the Act

71 Faecal microbiota transplant products--Part 3-3 of the Act

Subdivision C--Consumer medicine information documents

72 Consumer medicine information documents

Subdivision D--Handling and testing of samples

73 Handling and testing of samples

Subdivision E--Fee waivers and refunds for certain requests relating to prescription opioids

74 Fee waivers and refunds for certain requests relating to prescription opioids

Subdivision F--Clinical trials

75 Clinical trials

Division 13--Application and saving provisions relating to the Therapeutic Goods Legislation Amendment (2020 Measures No. 1) Regulations  2020

76 Approving supply of therapeutic goods under authorised prescriber scheme

77 Preliminary assessment of applications for variation of permissible ingredients determination

Division 15--Application provisions relating to the Minamata Convention on Mercury (Consequential Amendments) Regulations 2021

79 Application of amendments made by the Minamata Convention on Mercury (Consequential Amendments) Regulations  2021

Division 16--Application provisions relating to the Therapeutic Goods Legislation Amendment (2021 Measures No. 3) Regulations 2021

81 Access to medicines in emergency situations

82 Consumer medicine information documents

83 Approving supply of therapeutic goods under authorised prescriber scheme

Division 17--Application provisions relating to the Therapeutic Goods Legislation Amendment (2021 Measures No. 4) Regulations 2021

84 Amendments made by Division 1 of Part 2 of Schedule  1

85 Amendments made by Division 2 of Part 2 of Schedule  1

Division 18--Application provisions relating to Schedule 1 to the Therapeutic Goods Legislation Amendment (2022 Measures No. 1) Regulations  2022

86 Extemporaneously-compounded medicinal cannabis products

Division 19--Application provisions relating to Schedule 2 to the Therapeutic Goods Legislation Amendment (2022 Measures No. 1) Regulations  2022

87 Reconsideration of decisions

Division 20--Application provisions relating to the Therapeutic Goods Legislation Amendment (2022 Measures No. 3) Regulations 2022

88 Exempt goods

89 Fee for requests to vary entries in Register

Division 21--Application provisions relating to the Therapeutic Goods Legislation Amendment (2023 Measures No. 1) Regulations 2023

90 Clinical trials

Division 22--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2023 Measures No. 2) Regulations 2023

91 Clinical trials

92 Removal of exemptions for sunscreen preparations

Division 23--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (Vaping) Regulations 2023

93 Definitions

94 Approving supply of therapeutic goods under authorised prescriber scheme

95 Goods to be included in parts of the Register

96 Exempt goods

97 Transitional vaping manufacturers--exemption from Part 3-3 of the Act

Division 24--Application provision relating to the Therapeutic Goods Amendment (2024 Measures No. 1) Regulations 2024

98 Exempt goods

Division 25--Transitional provisions relating to the Therapeutic Goods Legislation Amendment (2024 Measures No. 2) Regulations 2024

99 Definitions

100 Fee waivers in relation to the Medicines Repurposing Program

101 Examination, testing and analysis of goods

102 Identity cards

103 Sunscreen preparations

Division 26--Application and transitional provisions relating to the Therapeutic Goods Legislation Amendment (Vaping Reforms) Regulations 2024

104 Definitions

105 Authorities for therapeutic vaping substances that are not medicines

106 Therapeutic vaping packs

107 Exempt goods

108 Transitional vaping goods--exemption from Part 3-2 of the Act

Division 27--Application, transitional and saving provisions relating to the Therapeutic Goods Legislation Amendment (2024 Measures No. 3) Regulations 2024

109 Definitions

110 Exempt therapeutic goods

111 Notices, statements and determinations

Schedule 1--Part 2 does not apply to members of an Australian branch of one of these bodies

Schedule 2--Prohibited and required representations

Part 1--Prohibited representations

Part 2--Required representations

Part 3--Vitamins referred to in Item 3 of Part 1 of this Schedule

Schedule 3--Therapeutic goods required to be included in the part of the Register for goods known as registered goods or as provisionally registered goods

Part 1--Medicines

Part 2--Therapeutic goods that are not medicines

Part 3--Therapeutic goods attracting no fee under Division 1 or 2 of Part 3-2 of the Act

Schedule 4--Therapeutic goods required to be included in the part of the Register for listed goods

Schedule 5--Therapeutic goods exempt from the operation of Parts 3-2 and 3-2A of the Act

Schedule 5A--Therapeutic goods exempt from operation of Parts 3-2 and 3-2A of Act subject to conditions

Schedule 5B--Disposal of unused emergency goods and unused emergency biologicals

1 Early end of exemption--notice of goods held

1A Early cessation of exemption--notice of biologicals held

2 Expiration of period of exemption--notice of goods held

2A Expiration of period of exemption--notice of biologicals held

3 Storage and disposal of unused emergency goods and unused emergency biologicals

4 Direction for disposal of unused emergency goods and unused emergency biologicals

5 Relocation of unused emergency goods and unused emergency biologicals

6 Disposal of unused emergency goods and unused emergency biologicals--destruction

7 Disposal of unused emergency goods and unused emergency biologicals--export

8 Disposal of unused emergency goods and unused emergency biologicals--supply

9 Owner to be paid for goods or biologicals supplied

10 Records about unused emergency goods and unused emergency biologicals

11 Failure to comply with this Schedule

Schedule 7--Therapeutic goods exempt from the operation of Part 3-3 of the Act unless supplied as pharmaceutical benefits

Schedule 8--Persons exempt from the operation of Part 3-3 of the Act

Schedule 9--Fees--therapeutic goods other than biologicals

Part 1--Interpretation

1 Definitions

2 Part 2 fees do not apply in relation to applications etc. covered by Part 3 or 4

Part 2--Table of fees other than for applications etc. covered by Part 3 or 4

3 Table of fees

Part 3--Table of fees for applications etc. in relation to certain OTC medicines

4 Table of fees

Part 4--Table of fees for applications etc. in relation to certain complementary medicines and certain other listed medicines

5 Table of fees

Schedule 9A--Fees--biologicals

Part 1--Interpretation of table

1 Definitions

Part 2--Table of fees

Schedule 10--Therapeutic goods for evaluation

Part 1--Evaluation of prescription and other medicines by the Prescription Medicines Authorisation Branch

Part 2--Evaluation of complementary medicines by the Complementary and OTC Medicines Branch

Part 3--Evaluation of non-prescription and other medicines by the Complementary and OTC Medicines Branch

Schedule 12--Consumer medicine information documents

1 General requirements

2 Specific requirements--document enclosed within packaging etc.

3 Specific requirements--document not enclosed within packaging etc.

Schedule 13--Consumer medicine information documents

1 General requirements

2 Specific requirements--document enclosed within packaging etc.

3 Specific requirements--document not enclosed within packaging etc.

Schedule 14--Designated active ingredients

Schedule 16--Classes of biologicals

1A Class 1 biologicals

1 Class 4 biologicals

Endnotes

Endnote 1--About the endnotes

Endnote 2--Abbreviation key

Endnote 3--Legislation history

Endnote 4--Amendment history

Endnotes

Endnote 1--About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1--About the endnotes

Endnote 2--Abbreviation key

Endnote 3--Legislation history

Endnote 4--Amendment history

Abbreviation key--Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history--Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and "(md not incorp)" is added to the amendment history.

Endnote 2--Abbreviation key

 

ad = added or inserted	o = order(s)
am = amended	Ord = Ordinance
amdt = amendment	orig = original
c = clause(s)	par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x	/sub-subparagraph(s)
Ch = Chapter(s)	pres = present
def = definition(s)	prev = previous
Dict = Dictionary	(prev ... ) = previously
disallowed = disallowed by Parliament	Pt = Part(s)
Div = Division(s)	r = regulation(s)/rule(s)
ed = editorial change	reloc = relocated
exp = expires/expired or ceases/ceased to have	renum = renumbered
effect	rep = repealed
F = Federal Register of Legislation	rs = repealed and substituted
gaz = gazette	s = section(s)/subsection(s)
LA = Legislation Act 2003	Sch = Schedule(s)
LIA = Legislative Instruments Act 2003	Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given	SLI = Select Legislative Instrument
effect	SR = Statutory Rules
(md not incorp) = misdescribed amendment	Sub-Ch = Sub-Chapter(s)
cannot be given effect	SubPt = Subpart(s)
mod = modified/modification	underlining = whole or part not
No. = Number(s)	commenced or to be commenced

Endnote 3--Legislation history

 

Number and year	FRLI registration or gazettal	Commencement	Application, saving and transitional provisions
1990 No. 394	6 Dec 1991	15 Feb 1991
1991 No. 84	30 Apr 1991	rr. 3.1, 5.2, 7.1, 10.2, 11.1, 12.2, 12.4, 13.1 and 14.1: 15 Feb 1991 Remainder: 30 Apr 1991	--
1991 No. 485	24 Dec 1991	24 Dec 1991	--
1992 No. 19	31 Jan 1992	r. 10: 1 July 1992 Remainder: 1 Feb 1992	--
1992 No. 89	14 Apr 1992	14 Apr 1992	--
1992 No. 109	28 Apr 1992	28 Apr 1992	--
1992 No. 332	27 Oct 1992	27 Oct 1992	--
1992 No. 370	30 Nov 1992	30 Nov 1992	--
1992 No. 430	24 Dec 1992	rr. 4 and 7: 1 Jan 1993 Remainder: 24 Dec 1992	--
1993 No. 141	25 June 1993	1 July 1993	--
1994 No. 150	2 June 1994	2 June 1994	r. 22
1994 No. 222	30 June 1994	1 July 1994	--
1994 No. 364	1 Nov 1994	1 Nov 1994	--
1995 No. 33	8 Mar 1995	8 Mar 1995	--
1995 No. 111	31 May 1995	1 June 1995	--
1995 No. 192	30 June 1995	1 July 1995	--
1995 No. 208	4 July 1995	rr. 6 and 9.3: 1 Oct 1995 rr. 8, 9.2, 10.6 and 11.7: 1 Jan 1996 r. 10.7: 1 Oct 1996 rr. 13.2 and 14.4: 1 Jan 1997 Remainder: 4 July 1995	r. 19
1995 No. 253	29 Aug 1995	29 Aug 1995	--
1995 No. 320	3 Nov 1995	3 Nov 1995	--
1995 No. 328	3 Nov 1995	6 Nov 1995 (see r. 1 and Gazette 1995, No. S423)	--
1996 No. 9	31 Jan 1996	31 Jan 1996	--
1996 No. 25	5 Feb 1996	5 Feb 1996 Note: disallowed by the House of Representatives on 10 Sept 1996	--
1996 No. 131	28 June 1996	1 July 1996	--
1996 No. 200	11 Sept 1996	11 Sept 1996	--
1996 No. 208	26 Sept 1996	26 Sept 1996	--
1997 No. 162	30 June 1997	1 July 1997	--
1997 No. 398	24 Dec 1997	24 Dec 1997	--
1997 No. 399	24 Dec 1997	rr. 1.1, 3.1, 9 and 10: 24 Dec 1997 Remainder: 1 Jan 1998	--
1997 No. 400	24 Dec 1997	24 Dec 1997	--
1997 No. 401 /span>	24 Dec 1997	24 Dec 1997 Note: disallowed by the Senate on 31 Mar 1998	--
1998 No. 227	16 July 1998	16 July 1998	--
1998 No. 247	31 July 1998	1 Aug 1998	--
1998 No. 369	22 Dec 1998	1 Jan 1999	--
1999 No. 62	16 Apr 1999	16 Apr 1999	--
1999 No. 209	16 Sept 1999	16 Sept 1999	r. 4
1999 No. 324	16 Dec 1999	16 Dec 1999	--
2000 No. 29	23 Mar 2000	rr. 1, 2 and 3(1) and Schedule 1: 23 Mar 2000 Remainder: 31 Mar 2000	--
2000 No. 48	19 Apr 2000	19 Apr 2000	--
2000 No. 70	12 May 2000	1 July 2000	--
2000 No. 123	22 June 2000	22 June 2000	--
2000 No. 124	22 June 2000	1 July 2000	--
2000 No. 267	28 Sept 2000	28 Sept 2000	--
2000 No. 358	20 Dec 2000	20 Dec 2000	--
2001 No. 159	29 June 2001	29 June 2001	--
2001 No. 160	29 June 2001	1 July 2001	--
2001 No. 252	20 Sept 2001	22 Sept 2001 (see r. 2)	--
2001 No. 343	21 Dec 2001	rr. 1-3 and Schedule 1: 30 Sept 2001 Remainder: 21 Dec 2001	--
2002 No. 9	21 Feb 2002	21 Feb 2002	--
2002 No. 84	9 May 2002	9 May 2002	--
2002 No. 114	7 June 2002	7 June 2002	--
2002 No. 143	27 June 2002	1 July 2002	--
2002 No. 234	4 Oct 2002	4 Oct 2002 (see r. 2)	--
2002 No. 315	19 Dec 2002	rr. 1-3 and Schedule 1: 19 Dec 2002 Remainder: 1 Jan 2003	--
2002 No. 345	20 Dec 2002	rr. 1-3 and Schedule 1: 20 Dec 2002 Remainder: 1 Jan 2003	--
2003 No. 111	13 June 2003	13 June 2003	--
2003 No. 151	26 June 2003	1 July 2003	--
2003 No. 257	16 Oct 2003	16 Oct 2003	--
2003 No. 258	16 Oct 2003	rr. 1-3 and Schedule 1: 16 Oct 2003 Remainder: 1 Oct 2004	--
2003 No. 301	5 Dec 2003	5 Dec 2003	--
2003 No.  /span>361	23 Dec 2003	23 Dec 2003	--
2004 No. 78	30 Apr 2004	30 Apr 2004	--
2004 No. 127	18 June 2004	1 July 2004	r. 4
2004 No. 159	25 June 2004	1 July 2004	--
2005 No. 192	19 Aug 2005 (F2005L02312)	20 Aug 2005	--
2006 No. 122	2 June 2006 (F2006L01615)	3 June 2006	--
2006 No. 212	10 Aug 2006 (F2006L02573)	11 Aug 2006	--
2007 No. 161	25 June 2007 (F2007L01521)	1 July 2007	--
2008 No. 117	20 June 2008 (F2008L01367)	1 July 2008	--
2009 No. 63	15 Apr 2009 (F200900839)	16 Apr 2009	--
2009 No. 140	25 June 2009 (F2009L01826)	26 June 2009	--
2009 No. 141	25 June 2009 (F2009L02019)	1 July 2009	--
2009 No. 179	9 July 2009 (F2009L02089)	10 July 2009	--
2009 No. 228	10 Sept 2009 (F2009L02935)	11 Sept 2009	--
2009 No. 374	16 Dec 2009 (F2009L04018)	rr. 1-4 and Schedule 1: 1 Jan 2010 Schedule 2: 25 Jan 2010	r. 4
2010 No. 26	3 Mar 2010 (F2010L00470)	1 July 2010	rr. 4-7
2010 No. 129	21 June 2010 (F2010L01285)	1 July 2010	--
2010 No. 130	21 June 2010 (F2010L01282)	1 July 2010	--
2010 No. 266	28 Oct 2010 (F2010L02771)	29 Oct 2010	r. 4
2011 No. 30	16 Mar 2011 (F2011L00434)	31 May 2011 (see r. 2)	--
2011 No. 102	21 June 2011 (F2011L01100)	1 July 2011	--
2011 No. 281	8 Dec 2011 (F2011L02595)	rr. 1-3 and Schedule 1: 9 Dec 2011 Schedule 2: 1 Mar 2012	--
2012 No. 142	29 June 2012 (F2012L01448)	30 June 2012	--
2012 No. 143	29 June 2012 (F2012L01455)	1 July 2012	--
2012 No. 251	9 Nov 2012 (F2012L02161)	10 Nov 2012	--
94, 2013	3 June 2013 (F2013L00896)	1 July 2013	--
220, 2013	6 Aug 2013 (F2013L01516)	7 Aug 2013	--
62, 2014	30 May 2014 (F2014L00630)	1 July 2014	--
63, 2014	30 May 2014 (F2014L00632)	1 July 2014	--
75, 2015	1 June 2015 (F2015L00778)	Sch 1 (items 1-6, 9-11): 1 July 2015 (s 2)	--
87, 2015	19 June 2015 (F2015L00854)	Sch 1 (items 2-6): 1 July 2015 (s 2(1) item  1)	--
90, 2015	18 June 2015 (F2015L00837)	Sch 2 (item 197): 1 July 2015 (s 2(1) item  2)	--
213, 2015	1 Dec 2015 (F2015L01909)	1 Jan 2016 (s 2(1) item 1)	--
214, 2015	1 Dec 2015 (F2015L01910)	1 Jan 2016 (s 2(1) item 1)	--

 

Name	Registration	Commencement	Application, saving and transitional provisions
Therapeutic Goods Legislation Amendment (Charges Exemptions and Other Measures) Regulation 2016	15 Feb 2016 (F2016L00109)	Sch 1: 1 July 2015 (s 2(1) item 2) Sch 2 and Sch 4 (items 6-35): 16 Feb 2016 (s 2(1) items 3, 5) Sch 4 (items 1-5): 16 Aug 2016 (s 2(1) item 4)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulation 2016	5 May 2016 (F2016L00667)	Sch 1 (items 2-10): 1 July 2016 (s 2(1) item 1)	--
Therapeutic Goods Amendment (Advisory Committees and Other Measures) Regulation 2016	14 Oct 2016 (F2016L01614)	Sch 1: 1 Jan 2017 (s 2(1) item 2) Remainder: 15 Oct 2016 (s 2(1) items 1, 3)	--
Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016	28 Oct 2016 (F2016L01652)	Sch 1 (items 1-8): 1 Nov 2016 (s 2(1) item 2) Note: Sch 1 (items 1, 4) were disallowed by the Senate on 13 June 2017 at 13:07	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2017	19 May 2017 (F2017L00552)	Sch 1 (items 3-5): 1 July 2017 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2017 Measures No. 1) Regulations 2017	30 June 2017 (F2017L00853)	Sch 1 (items 1-3), Sch 2 (items 7-19), Sch 3-5, Sch 6 (item 2), Sch 7, Sch 8 (items  7-9) and Sch 9: 1 July 2017 (s 2(1) items 2, 4) Sch 1 (items 4-7): 4 Dec 2017 (s 2(1) item 3)	--
as amended by
Therapeutic Goods Legislation Amendment (2017 Measures No. 2) Regulations 2017	1 Dec 2017 (F2017L01561)	Sch 2 (item 1): 2 Dec 2017 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (2017 Measures No. 2) Regulations 2017	1 Dec 2017 (F2017L01561)	Sch 2 (items 2-12): 4 Dec 2017 (s 2(1) item 4) Sch 3: 1 Jan 2018 (s 2(1) item 5) Sch 4 (items 1-4, 6, 11-17): 2 Dec 2017 (s 2(1) item 6)	--
Therapeutic Goods Legislation Amendment (2018 Measures No. 1) Regulations 2018	19 Mar 2018 (F2018L00311)	Sch 1, Sch 2, Sch 4 (items 1-11), Sch 5 and Sch 6 (items 9-42): 20 Mar 2018 (s 2(1) items 2, 3, 5, 8) Sch 4 (items 12-16): 1 July 2020 (s 2(1) item 6) Sch 4 (items 17-23): 1 July 2018 (s 2(1) item 7)	--
Therapeutic Goods Legislation Amendment (Exempt Devices and Goods) Regulations 2018	26 Apr 2018 (F2018L00516)	Sch 1 (items 6-10): 27 Apr 2018 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2018	12 June 2018 (F2018L00759)	Sch 1 (items 5-16): 1 July 2018 (s 2(1) item 2) Sch 1 (items 17, 18): 1 July 2019 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (2018 Measures No. 2) Regulations 2018	25 June 2018 (F2018L00865)	Sch 1 (items 4-29): 1 July 2018 (s 2(1) items 2, 3) Note: This amending title was affected by an editorial change (see F2018C00390)	--
Therapeutic Goods Legislation Amendment (2018 Measures No. 3) Regulations 2018	15 Oct 2018 (F2018L01434)	Sch 1 (items 3-34): 16 Oct 2018 (s 2(1) item 2) Sch 1 (items 37-49): 1 Jan 2019 (s 2(1) item 3)	--
Therapeutic Goods Amendment (2018 Measures No. 1) Regulations 2018	26 Nov 2018 (F2018L01612)	27 Nov 2018 (s 2(1) item 1)	--
Therapeutic Goods Amendment (Scheduling Advisory Committee Members) Regulations 2019	8 Feb 2019 (F2019L00109)	9 Feb 2019 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2019	25 Mar 2019 (F2019L00396)	Sch 1 (items 4-26): 1 July 2019 (s 2(1) items 2, 3)	--
Therapeutic Goods Amendment (Fees for Relisted Medicine) Regulations 2019	25 Sept 2019 (F2019L01260)	26 Sept 2019 (s 2(1) item 1)	--
Therapeutic Goods Amendment (Approval of Advertisements) Regulations 2019	14 Nov 2019 (F2019L01465)	15 Nov 2019 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2019 Measures No. 1) Regulations 2019	18 Dec 2019 (F2019L01660)	Sch 5, 7 and Sch 9 (items 1-10): 1 Jan 2020 (s 2(1) items 4, 6, 8) Sch 6: 1 Jan 2021 (s 2(1) item 5) Sch 8, Sch 9 (items 11-13) and Sch 10 (item 2): 19 Dec 2019 (s 2(1) items 7, 9, 10)	--
Therapeutic Goods Amendment (Radiopharmaceuticals and Radiopharmaceutical Active Ingredients) Regulations 2020	1 May 2020 (F2020L00544)	2 May 2020 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2020	15 June 2020 (F2020L00720)	Sch 1 (items 2, 4-27): 1 July 2020 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2020 Measures No. 1) Regulations 2020	23 July 2020 (F2020L00946)	Sch 4, Sch 8 (items 24-31), Sch 9 and Sch 10 (item 2): 24 July 2020 (s 2(1) items 3, 7, 9) Sch 5 and 6: 23 July 2020 (s 2(1) items 4, 5)	--
Therapeutic Goods Legislation Amendment (2020 Measures No. 2) Regulations 2020	14 Dec 2020 (F2020L01598)	Sch 1 (items 3-10): 15 Dec 2020 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (2021 Measures No. 1) Regulations 2021	16 Apr 2021 (F2021L00450)	Sch 1 (items 1, 2): 19 Apr 2021 (s 2(1) item 2) Sch 1 (item 3): 17 Apr 2021 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (Fees) Regulations 2021	3 June 2021 (F2021L00688)	Sch 1 (items 2, 3): 1 July 2021 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2021 Measures No. 2) Regulations 2021	27 July 2021 (F2021L01032)	Sch 1 (items 1, 2, 6-8, 13, 15): 28 July 2021 (s 2(1) item 1)	--
Minamata Convention on Mercury (Consequential Amendments) Regulations 2021	5 Oct 2021 (F2021L01390)	Sch 1 (items 57-59): 7 Mar 2022 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2021 Measures No. 3) Regulations 2021	28 Oct 2021 (F2021L01474)	Sch 1 (items 54-61, 70-82, 87): 29 Oct 2021 (s 2(1) item 7)	--
Therapeutic Goods Legislation Amendment (2021 Measures No. 4) Regulations 2021	17 Dec 2021 (F2021L01809)	Sch 1 (items 5-10): 18 Dec 2021 (s 2(1) item 3) Sch 1 (items 11-18): 1 Jan 2022 (s 2(1) item 4)	--
Therapeutic Goods Legislation Amendment (2022 Measures No. 1) Regulations 2022	4 Mar 2022 (F2022L00243)	Sch 1 (items 3, 4): 31 Mar 2022 (s 2(1) item 2) Sch 2: 7 Mar 2022 (s 2(1) item 3) Sch 3 (item 4): 5 Mar 2022 (s 2(1) item 4)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2022	13 Apr 2022 (F2022L00600)	Sch 1 (items 5-11): 1 July 2022 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2022 Measures No. 2) Regulations 2022	30 Sept 2022 (F2022L01300)	Sch 3: 1 Oct 2022 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (2022 Measures No. 3) Regulations 2022	19 Dec 2022 (F2022L01687)	Sch 2: 20 Dec 2022 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2023 Measures No. 1) Regulations 2023	13 June 2023 (F2023L00769)	Sch 1 (items 1-13): 21 June 2023 (s 2(1) item 2) Sch 1 (items 20-28, 30, 52, 54): 14 June 2023 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2023	13 June 2023 (F2023L00770)	Sch 1 (items 7-13): 1 July 2023 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2023 Measures No. 2) Regulations 2023	27 Nov 2023 (F2023L01558)	Sch 1 (items 13-23, 34): 28 Nov 2023 (s 2(1) items 2, 4) Sch 1 (items 24-32): 1 Jan 2024 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (Vaping) Regulations 2023	14 Dec 2023 (F2023L01667)	Sch 1: 1 Jan 2024 (s 2(1) item 1)	--
Therapeutic Goods Amendment (2024 Measures No. 1) Regulations 2024	29 Feb 2024 (F2024L00260)	1 Mar 2024 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2024 Measures No. 2) Regulations 2024	14 June 2024 (F2024L00686)	Sch 1 (items 1-4, 8-16, 18): 15 June 2024 (s 2(1) item 2) Sch 2 (items 1, 2, 11): 1 July 2024 (s 2(1) item 3) Sch 3: 1 Oct 2024 (s 2(1) item 4)	--
Therapeutic Goods Legislation Amendment (Fees and Other Measures) Regulations 2024	17 June 2024 (F2024L00689)	Sch 1 (items 15-21): 1 July 2024 (s 2(1) item 2) Sch 2: 1 Jan 2025 (s 2(1) item 3)	--
Therapeutic Goods Legislation Amendment (Vaping Reforms) Regulations 2024	28 June 2024 (F2024L00839)	Sch 1 (items 16-32, 35, 36): 1 July 2024 (s 2(1) item 2) Sch 2: 1 Oct 2024 (s 2(1) item 3) Sch 3: 30 Aug 2024 (s 2(1) item 4)	--
Administrative Review Tribunal Legislation Consequential Amendments (2024 Measures No. 1) Regulations 2024	11 Oct 2024 (F2024L01299)	Sch 7 (items 28-33): 14 Oct 2024 (s 2(1) item 1)	--
Therapeutic Goods Legislation Amendment (2024 Measures No. 3) Regulations 2024	13 Dec 2024 (F2024L01673)	Sch 1 (items 8-15, 17): 14 Dec 2024 (s 2(1) item 1)	--

 

Act	Number and year	Assent	Commencement	Application, saving and transitional provisions
Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024	50, 2024	27 June 2024	Sch 4 (items 17-19): 1 Oct 2024 (s 2(1) item 5)	Sch 4 (items 18, 19)

Endnote 4--Amendment history

 

Provision affected	How affected
Part 1
r 1.....................	rs No 369, 1998
r 2.....................	am No 485, 1991; No 332, 1992; No 364, 1994; No 111, 1995; No 208, 1995; No 328, 1995; No 398, 1997; No 399, 1997; No 400, 1997; No  369, 1998; No 62, 1999; No 324, 1999; No 29, 2000; No 48, 2000; No 358, 2000; No 159, 2001; No 234, 2002; No 111, 2003; No 151, 2003; No 301, 2003; No 361, 2003; No  127, 2004; No 374, 2009; No 26, 2010; No 30, 2011; No 102, 2011; No 251, 2012; No 75, 2015; No 214, 2015; F2016L00109; F2016L01614; F2017L00853; F2017L01561; F2018L00311; F2018L00865; F2018L01434; F2019L00396
	ed C88
	am F2019L01465; F2019L01660; F2020L00720; F2020L00946 (amdt never applied (Sch 9 item 1)); F2021L01032; F2021L01390; F2022L01300; F2022L01687; F2023L00769; F2023L01667; F2024L00686; F2024L00839
r 2A....................	ad No 361, 2003
r 3.....................	am No 89, 1992; No 430, 1992
	rs No 111, 1995
	am No 200, 1996
	rs No 361, 2003
	am No 26, 2010; No 102, 2011; No 281, 2011; No 87, 2015
	ed C88
	am F2021L01474; F2024L00839
r 3AA...................	ad No 102, 2011
	am No 213, 2015; F2018L00311; F2018L01434
r 3A....................	ad 2003 No 301
	am 2005 No 192; F2017L00853
r 3B....................	ad F2018L00865
r 3C....................	ad F2023L00769
Part 2
Division 1
Division 1 heading..........	ad No 400, 1997
Division 1................	rs No 301, 2003
r 4.....................	am No 19, 1992; No 159, 2001
	rs No 301, 2003
r 4A....................	ad No 301, 2003
r 5.....................	rep No 301, 2003
r 5A....................	ad No 19, 1992
	rep No 301, 2003
Division 2................	ad No 400, 1997
	rep F2018L00311
r 5B....................	ad No 400, 1997
	am No 227, 1998; No 369, 1998; No 62, 1999; No 48, 2000; No 159, 2001; No 234, 2002; No  301, 2003; F2019L01465
	rep F2018L00311
r 5BA...................	ad No 301, 2003
	rep F2018L00311
r 5C....................	ad No 400, 1997
	am No 159, 2001
	rep F2018L00311
r 5D....................	ad No 400, 1997
	rep No 62, 1999
r 5E....................	ad No 400, 1997
	rep No 62, 1999
r 5F....................	ad No 400, 1997
	am No 324, 1999
	rep F2018L00311
r 5G....................	ad No 400, 1997
	am No 324, 1999; No 48, 2000; No 301, 2003
	rep F2018L00311
r 5H....................	ad No 400, 1997
	rep F2018L00311
r 5J.....................	ad No 400, 1997
	am No 48, 2000
	rep F2018L00311
r 5K....................	ad No 400, 1997
	rep F2018L00311
r 5L....................	ad No 400, 1997
	am No 62, 1999; No 48, 2000; F2018L00311
	rep F2018L00311
r 5M....................	ad No 400, 1997
	am F2016L00109; F2018L00311
	rep F2018L00311
r 5N....................	ad No 400, 1997
	am F2018L00311
	rep F2018L00311
r 5P....................	ad No 400, 1997
	rep F2018L00311
r 5Q....................	ad No 400, 1997
	am No 369, 1998; No 48, 2000; No 159, 2001; No 301, 2003; No 281, 2011; F2016L00109; F2018L00311; F2019L01465
	rep F2018L00311
Division 3
Division 3 heading..........	ad. 1997 No. 400
	rs. 2003 No. 301
Division 3................	rs. 2003 No. 301
r. 5R....................	ad. 1997 No. 400
	rep. 2003 No. 301
r 6.....................	am 1992 No. 19; 1995 No. 253; 1996 No. 9; 1998 No. 227; 2000 No.  48; 2001 No. 159; 2002 Nos. 9 and 234
	rs. 2003 No. 301
	rep F2018L00311
r 6AA...................	ad. 2000 No. 48
	rep. 2003 No. 301
	ad. 2009 No. 374
	am F2016L01614; F2018L00311
r 6AB...................	ad. 2000 No. 48
	rep. 2003 No. 301
r 6A....................	ad No 208, 1995
	rs No 301, 2003; No 192, 2005
	rep F2018L00311
r 6B....................	ad 2003 No 301
	am F2018L01434; F2021L01809
r 7.....................	rs No 301, 2003
	am F2016L00109
	rs F2018L00311
	am F2021L01809; F2022L01687
r 7A....................	ad No 48, 2000
	rep No 301, 2003
	ad F2018L00311
r 7B....................	ad No 48, 2000
	rep No 301, 2003
r 7C....................	ad No 48, 2000
	rep No 301, 2003
r 7D....................	ad No 48, 2000
	rep No 301, 2003
r 7E....................	ad No 48, 2000
	rep No 301, 2003
r 7F....................	ad No 48, 2000
	rep No 301, 2003
r 7G....................	ad No 48, 2000
	rep No 301, 2003
r 7H....................	ad No 48, 2000
	rep No 301, 2003
r. 7J....................	ad. 2000 No. 48
	rep. 2003 No. 301
Division 4
Division 4 heading..........	ad. 1997 No. 400
	rs. 2003 No. 301
Division 4................	rs. 2003 No. 301
r 8.....................	am No 400, 1997
	rs No 301, 2003
	am No 122, 2006; F2018L00311; F2018L01434; F2021L01809
r 8A....................	ad No 301, 2003
	am No 122, 2006
	rep F2018L00311
Division 5................	ad No 400, 1997
	rep No 48, 2000
	ad No 301, 2003
	rep F2018L00311
r 9.....................	rs No 48, 2000; No 301, 2003
	rep F2018L00311
r. 9AA..................	ad. 1997 No. 400
	rs. 2000 No. 48
	am. 2002 No. 315
	rep. 2003 No. 301
rr. 9AB-9AE..............	ad. 1997 No. 400
	rep. 2000 No. 48
Part 2A
Part 2A..................	ad. 1992 No. 430
r 9A....................	ad 1992 No 430
	am. 1994 No. 364; 1995 No. 208; 1998 No. 369; 1999 No. 62; 2002 Nos. 9 and 315; 2003 No.  257; F2019L01660; F2021L01474
r 9B....................	ad No 257, 2003
	am No 102, 2011; F2018L00311; F2019L01660
Part 2B..................	ad. 2000 No. 48
	rep. 2003 No. 301
r. 9P....................	ad. 2000 No. 48
	rep. 2003 No. 301
r. 9Q....................	ad. 2000 No. 48
	rep. 2003 No. 301
r. 9R....................	ad. 2000 No. 48
	am. 2002 No. 9
	rep. 2003 No. 301
r. 9S....................	ad. 2000 No. 48
	am. 2002 No. 315
	rep. 2003 No. 301
Part 2C
Part 2C..................	ad. 2002 No. 234
Division 2C.1
r 10....................	rs No 234, 2002
	am No 213, 2015; F2018L00311
r 10AAA.................	ad F2017L00853
	am F2017L01561
r 10AAB.................	ad F2017L00853
	am F2017L01561; F2018L00865
r 10AAC.................	ad F2017L00853
	am F2017L01561
r 10AAD.................	ad F2017L01561
	am F2023L00769
r 10A (prev r 13)............	rep F2016L00109
r 10AA..................	ad No 214, 2015
	am F2017L01561; F2018L00311; F2019L00396
r 10AB..................	ad F2016L00109
r 10AC..................	ad F2016L00109
r 10B (prev r 14)............	rs No 30, 2011
r 10C (prev r 14A)...........	am F2020L00946
r. 10D...................	ad. 2002 No. 234
Division 2C.2
r. 10E...................	ad. 2002 No. 234
r. 10F...................	ad. 2002 No. 234
	am. 2009 No. 140
	rs F2016L00109
r 10FA..................	ad F2016L00109
Division 2C.3
Division 2C.3..............	ad. 2011 No. 30
r. 10G...................	ad. 2011 No. 30
r. 10H...................	ad. 2011 No. 30
	am. 2011 No. 281
	rs F2016L00109
r 10HA..................	ad F2016L00109
r. 10I...................	ad. 2011 No. 30
r. 10J...................	ad. 2011 No. 30
Part 2CA
Part 2CA.................	ad F2021L01390
Division 1
r 10JA...................	ad F2021L01390
Division 2
r 10JB...................	ad F2021L01390
Division 3
r 10JC...................	ad F2021L01390
Division 4
r 10JD...................	ad F2021L01390
r 10JE...................	ad F2021L01390
r 10JF	ad F2021L01390
Division 5
r 10JG...................	ad F2021L01390
r 10JH...................	ad F2021L01390
Part 2D
Part 2D..................	ad F2018L00311
r 10K...................	ad F2018L00311
r 10L...................	ad F2018L00311
	am F2021L01032
Part 2E
Part 2E..................	ad F2020L00946
r 10M...................	ad F2020L00946
Part 2F
Part 2F..................	ad F2024L00839
r 10N...................	ad F2024L00839
	am F2024L00839; F2024L01673
r 10P...................	ad F2024L00839
r 10Q...................	ad F2024L00839
Part 3
Part 3 heading.............	rs. 2011 No. 30
r 10A...................	ad No 252, 2001
	renum No 234, 2002
r 11 (prev r 10A)............	am No 127, 2004; F2018L00311
r. 11....................	am. 1992 No. 89; 1994 No. 150
	rep. 2002 No. 234
r 11A...................	ad 1994 No 150
	rep 2002 No 234
	ad 2011 No 30
	am F2016L01614; F2023L00769
r. 12....................	am. 1991 No. 84; 1992 No. 89; 1995 No. 33; 1996 No. 9; 2000 No.  358; 2001 No. 343; 2002 Nos. 84, 234 and 345; 2003 No. 258; 2010 No. 26
	rs. 2011 No. 30
	am F2021L01032; F2023L01667
r 12A...................	ad 1991 No 485
	am 1999 No 62; 2000 No 358; 2002 Nos 9 and 234; 2011 No 30; F2016L01652 (Sch 1 item 1 disallowed); F2017L00853; F2017L01561; F2022L00243
r. 12AAA................	ad. 2003 No. 111
	rep. 2010 No. 266
r. 12AAB................	ad. 2003 No. 111
	am. 2011 No. 30
r. 12AA..................	ad. 2000 No. 358
	am. 2011 No. 30
r 12AB..................	ad No 358, 2000
	am No 258, 2003; No 361, 2003; No 30, 2011; F2016L0109; F2019L01660
r 12AC..................	ad No 358, 2000
	am No 361, 2003; F2019L01660; F2023L00769; F2023L01558; F2024L00686
r 12AD..................	ad No 358, 2000
	am No 234, 2002; No 30, 2011; F2019L01660
r 12B...................	ad 1991 No 485
	am No 19, 1992; No 62, 1999; No 358, 2000; No 258, 2003; No 361, 2003; No  30, 2011; F2017L00853; F2020L00946; F2020L01598; F2021L01474; F2021L01809; F2022L01687; F2023L00769; F2023L01558; F2023L01667
r 12BA..................	ad F2024L00839
r 12C...................	ad 2002 No 234
	rep 2010 No 26
	ad 2011 No 30
	am F2017L00853
r 13....................	am No 19, 1992; No 9, 2002
	reloc and renum No 234, 2002
r 14....................	am No 9, 2002; No 234, 2002
	reloc and renum No 234, 2002
r 14A...................	ad No 430, 1992
	reloc and renum No 234, 2002
r 14B...................	ad 1992 No 430
	rep 2002 No 234
r 14C...................	ad 1992 No 430
	rep 2002 No 234
r 15....................	am No 19, 1992; No 398, 1997; No 62, 1999; No 102, 2011; F2018L00311; F2020L00946
r 15AA..................	ad F2021L00450
r 15A...................	ad 2003 No 258
	am 2010 No 26; 2011 No 102
	rs 2012 No 251
	am F2017L00853
r 16....................	am No 89, 1992; No 26, 2010
	rep F2020L00946
r. 16AA..................	ad. 2003 No. 151
	rs No 75, 2015
r 16AB..................	ad No 30, 2011
	am F2018L00865; F2018L01434
Part 3A
Part 3A heading............	am. 1999 No. 62
	rs. 2000 No. 29
Part 3A..................	ad. 1992 No. 19
Division 1
Division 1 heading..........	ad. 2000 No. 29
	rs F2017L01561
r. 16A...................	ad. 1992 No. 19
	am. 2011 No. 281
Division 1A
Division 1A heading.........	ad F2017L01561
r. 16B...................	ad. 1992 No. 19
	rep F2017L01561
r. 16C...................	ad. 1992 No. 19
	am. 1992 No. 109; 1998 No. 227; 1999 No. 62; F2016L00109
	rs F2017L01561
	am F2018L00311
r. 16D...................	ad. 1992 No. 19
	am. 1992 No. 109; 1998 No. 227; 1999 No. 62; 2003 No. 151
	rs F2017L01561
r 16DA..................	ad F2017L01561
	am F2018L00865
r. 16E...................	ad. 1992 No. 19
	am F2017L01561
r. 16F...................	ad. 1992 No. 19
	am. 1998 No. 227; 1999 No. 62; 2003 No. 151; F2017L01561
r. 16G...................	ad. 1992 No. 109
	am. 1998 No. 227; 1999 No. 62; F2017L01561
Division 2
Division 2................	ad. 2000 No. 29
r 16GA..................	ad No 29, 2000
	am No 151, 2003; F2018L00311
Division 3
Division 3................	ad. 2011 No. 30
r 16GB..................	ad No 30, 2011
	am No 281, 2011
	rep F2018L00311
r 16GC..................	ad No 30, 2011
	am No 281, 2011
	rs F2018L00311
r 16GD..................	ad No 30, 2011
	am No 281, 2011
	rs F2018L00311
r 16GE..................	ad No 30, 2011
	am F2018L00311
r 16GF..................	ad No 30, 2011
	am F2018L00311
Division 4
Division 4 heading..........	am F2018L01434
Division 4................	ad F2018L00311
r 16GG..................	ad F2018L00311
	am F2019L00396
r 16GH..................	ad F2018L00311
	am F2018L01434; F2019L00396
r 16GI...................	ad F2018L00311
	am F2020L00946
r 16GIA.................	ad F2021L00450
r 16GJ...................	ad F2018L00311
	am F2018L01434
Part 3B
Part 3B..................	ad 1997 No 399
	rs F2017L00853
r 16H...................	ad 1997 No 399
	am 1999 No 62
	rs F2017L00853
r 16I....................	ad 1997 No 399
	am 1999 No 62
	rep F2017L00853
r 16J....................	ad 1997 No 399
	am 1999 No 62; F2016L00109
	rs F2017L00853
	am F2018L00311
r 16K...................	ad F2017L00853
r 16L...................	ad F2017L00853
r 16M...................	ad F2017L00853
	am F2019L01660
Part 3C
Part 3C..................	ad F2017L00853
r 16P...................	ad F2017L00853
r 16Q...................	ad F2017L00853
r 16R...................	ad F2017L00853
	am F2018L00311
r 16S...................	ad F2017L00853
	am F2018L00311
r 16T...................	ad F2017L00853
	am F2018L00311
Part 3D
Part 3D..................	ad F2022L01300
r 16U...................	ad F2022L01300
r 16V...................	ad F2022L01300
	am F2023L00769
r 16W...................	ad F2022L01300
r 16X...................	ad F2022L01300
r 16Y...................	ad F2022L01300
Part 4
r. 17....................	am. 1994 No. 150; 2002 No. 234
r. 18....................	am. 2002 No. 234
r. 22....................	am. 1992 Nos. 19 and 89
Part 5
r 23....................	am No 150, 1994; No 252, 2001; No 234, 2002; No 361, 2003; F2018L00311; F2019L01660; F2024L00686
r 24....................	am. 1991 No. 84; 2002 No. 234; 2004 No. 78
r 25....................	am No 150, 1994; No 252, 2001; No 234, 2002; F2016L00109; F2018L00311; F2019L01660
r 26....................	am No 150, 1994; No 252, 2001; F2019L01660
r 26A...................	ad No 252, 2001
	am No 234, 2002; F2018L00311; F2019L01660
r 27....................	rs. 1994 No. 150
	am. 2002 No. 234; F2019L01660
r 28....................	am No 234, 2002; F2019L01660
r 29....................	am No 150, 1994; No 364, 1994; No 252, 2001; No 234, 2002; F2019L01660
r 30....................	am No 234, 2002; No 361, 2003; F2019L01660
r 31....................	am No 252, 2001; No 234, 2002; F2018L00311
r. 32....................	am. 1994 No. 150; 2002 No. 9
r 33....................	am No 9, 2002
	rs F2024L00686
Part 5A
Part 5A..................	ad. 2011 No. 30
r. 33A...................	ad. 2011 No. 30
r. 33B...................	ad. 2011 No. 30
r. 33C...................	ad. 2011 No. 30
Part 6
Division 1
Division 1 heading..........	ad. 1997 No. 400
	rs. 2002 No. 234; 2009 No. 374
	rep F2016L01614
Division 1................	rs. 2009 No. 374
	rep F2016L01614
r. 34....................	am. 1995 No. 208; 1999 No. 62; 2002 No. 234
	rs. 2009 No. 374
	rep F2016L01614
r. 34A...................	ad. 2009 No. 374
	am. 2011 No. 30; 2012 No. 251; No. 220, 2013
	rep F2016L01614
r. 34B...................	ad. 2009 No. 374
	rep F2016L01614
Division 1A
Division 1A heading.........	rs F2016L01614
Division 1A...............	ad. 2009 No. 374
r 35....................	am. 1991 No. 485; 1999 No. 62
	rs 2002 No 234; 2009 No 374; F2016L01614
r 35A...................	ad 2009 No 374
	am 2012 No 251; No 220, 2013; F2016L01614; F2024L00686
r 35B...................	ad 2009 No 374
	am 2011 No 102; F2016L01614
Division 1B
Division 1B...............	ad 2009 No 374
	rep F2016L01614
r. 36....................	am. 1991 No. 485; 1999 No. 62; 2002 No. 234
	rs. 2009 No. 374
	rep F2016L01614
r. 36A...................	ad. 2009 No. 374
	am. 2012 No. 251; No. 220, 2013
	rep F2016L01614
r. 36B...................	ad. 2009 No. 374
	am. 2011 No. 102
	rep F2016L01614
Division 1C
Division 1C...............	ad 2009 No 374
	rep F2016L01614
r. 37....................	am. 1997 No. 400
	rs. 2009 No. 374
	rep F2016L01614
r. 37A...................	ad. 2009 No. 374
	am. 2012 No. 251; No. 220, 2013
	rep F2016L01614
r. 37B...................	ad. 2009 No. 374
	am. 2011 No. 102; No. 220, 2013
	rep F2016L01614
Division 1D
Division 1D...............	ad. 2009 No. 374
r. 38....................	am. 1991 No. 485; 1997 No. 400; 2002 No. 234; 2009 No. 63
	rs. 2009 No. 374
r 38A...................	ad 2009 No 374
	am 2012 No 251; F2016L01614
r 38B...................	ad 2009 No 374
	am 2011 Nos 102 and 281; No 220, 2013; F2016L01614
Division 1DA
Division 1DA..............	ad 2011 No 281
	rep F2016L01614
r. 38C...................	ad. 2011 No. 281
	rep F2016L01614
r. 38D...................	ad. 2011 No. 281
	am. 2012 No. 251; No. 220, 2013
	rep F2016L01614
r. 38E...................	ad. 2011 No. 281
	am No. 220, 2013
	rep F2016L01614
r. 39....................	am. 1997 No. 400
	rep. 2009 No. 374
Division 1E
Division 1E...............	ad. 2009 No. 374
r. 39....................	ad. 2009 No. 374
r 39A...................	ad 2009 No 374
	am 2012 No 251; No 220, 2013; F2016L01614
r 39B...................	ad 2009 No 374
	am 2011 No 102; F2016L01614
Division 1EA
Division 1EA..............	ad. 2011 No. 30
r. 39C...................	ad. 2011 No. 30
r 39D...................	ad 2011 No 30
	am 2012 No 251; No 220, 2013; F2016L01614
r 39E...................	ad 2011 No 30
	am F2016L01614
Division 1EB
Division 1EB heading........	rs F2016L01614
Division 1EB..............	ad 2012 No 251
r 39F...................	ad 2012 No 251
	rs F2016L01614
r 39G...................	ad 2012 No 251
	am No 220, 2013; F2016L01614
r 39H...................	ad 2012 No 251
	am No 220, 2013; F2016L01614
Division 1F
Division 1F...............	ad. 2009 No. 374
r 40....................	am 1997 No 400
	rs 2009 No 374
	am 2009 No 374; 2011 Nos 30 and 281; 2012 No 251; F2016L01614
r. 41....................	am. 1991 No. 485; 1997 No. 400; 2002 No. 234
	rs. 2009 No. 374
r. 41A...................	ad. 2009 No. 374
r. 41B...................	ad. 2009 No. 374
r. 41C...................	ad. 2009 No. 374
	am. 2011 No. 102
r. 41D...................	ad. 2009 No. 374
r. 41E...................	ad. 2009 No. 374
r. 41F...................	ad. 2009 No. 374
r. 41G...................	ad. 2009 No. 374
r. 41H...................	ad. 2009 No. 374
r. 41I...................	ad. 2009 No. 374
r. 41J...................	ad. 2009 No. 374
r. 42....................	am. 1997 No. 400
	rs. 2009 No. 374
	am. 2011 No. 102; 2012 No. 251; F2016L00109
Division 2................	ad No 400, 1997
	rep F2018L00311
r 42A...................	ad No 400, 1997
	rep F2018L00311
r 42B...................	ad No 400, 1997
	am No 159, 2001; No 301, 2003
	rep F2018L00311
r 42C...................	ad No 400, 1997
	am No 369, 1998; No 234, 2002; No 111, 2003; No 258, 2003; No 122, 2006; No 102, 2011
	rep F2018L00311
r 42D...................	ad No 400, 1997
	am No 361, 2003
	rep F2018L00311
r 42E...................	ad No 400, 1997
	am No 369, 1998; No 234, 2002; No 111, 2003
	rep F2018L00311
r 42F...................	ad No 400, 1997
	rep F2018L00311
r 42G...................	ad No 400, 1997
	rep F2018L00311
r 42H...................	ad No 400, 1997
	am No 48, 2000
	rep F2018L00311
r 42J....................	ad No 400, 1997
	am No 48, 2000; No 159, 2001; No 315, 2002; No 258, 2003; No 361, 2003; No  122, 2006; No 63, 2009
	rep F2018L00311
r 42K...................	ad No 400, 1997
	am No 369, 1998; No 234, 2002; No 111, 2003
	rep F2018L00311
r 42L...................	ad No 400, 1997
	rep F2018L00311
r 42M...................	ad No 400, 1997
	rep F2018L00311
r 42N...................	ad No 400, 1997
	am No 102, 2011
	rep F2018L00311
r 42P...................	ad No 400, 1997
	rep F2018L00311
r 42Q...................	ad No 400, 1997
	rep F2018L00311
Division 3 heading..........	rs No 48, 2000
	rep F2018L00311
Division 3................	ad No 400, 1997
	rep F2018L00311
Subdivision 1 heading........	ad No 48, 2000
	rep F2018L00311
r 42R...................	ad No 400, 1997
	rep F2018L00311
r 42S...................	ad No 400, 1997
	am No 48, 2000
	rep F2018L00311
r 42T...................	ad No 400, 1997
	am No 369, 1998; No 48, 2000; No 234, 2002; No 102, 2011
	rep F2018L00311
r 42U...................	ad No 400, 1997
	am No 361, 2003
	rep F2018L00311
r 42V...................	ad No 400, 1997
	rep F2018L00311
r 42W...................	ad No 400, 1997
	am No 48, 2000
	rep F2018L00311
r 42X...................	ad No 400, 1997
	am No 258, 2003
	rep F2018L00311
r 42Y...................	ad No 400, 1997
	am No 369, 1998; No 48, 2000; No 234, 2002; No 315, 2002; No 111, 2003; No 102, 2011
	rs No 301, 2003
	rep F2018L00311
r 42Z...................	ad No 400, 1997
	rep F2018L00311
r 42ZA..................	ad No 400, 1997
	rep F2018L00311
r 42ZB..................	ad No 400, 1997
	am No 102, 2011
	rep F2018L00311
r 42ZC..................	ad No 400, 1997
	rs No 48, 2000
	rep F2018L00311
Subdivision 2..............	ad No 48, 2000
	rep F2018L00311
r 42ZCAA................	ad No 48, 2000
	am No 159, 2001; No 142, 2012
	rep F2018L00311
r 42ZCAB................	ad No 48, 2000
	am No 159, 2001; No 234, 2002; No 301, 2003; No 159, 2004
	rep F2018L00311
r 42ZCAC................	ad No 48, 2000
	rep F2018L00311
r 42ZCAD................	ad No 48, 2000
	am No 315, 2002; No 111, 2003
	rep F2018L00311
r 42ZCAE................	ad No 48, 2000
	rep F2018L00311
r 42ZCAF................	ad No 48, 2000
	rep F2018L00311
r 42ZCAG................	ad No 48, 2000
	rep F2018L00311
r 42ZCAGA...............	ad No 122, 2006
	rep F2018L00311
r 42ZCAH................	ad No 48, 2000
	rep F2018L00311
r 42ZCAI.................	ad No 48, 2000
	am No 234, 2002; No 315, 2002; No 301, 2003; No 122, 2006; No 102, 2011
	rep F2018L00311
r 42ZCAJ................	ad No 48, 2000
	am No 142, 2012
	rep F2018L00311
r 42ZCAK................	ad No 48, 2000
	rep F2018L00311
r 42ZCAL................	ad No 315, 2002
	rep F2018L00311
Division 3A
Division 3A...............	ad. 1999 No. 209
	rs. 2010 No. 129
Subdivision 3A.1
Subdivision 1.............. renumbered Subdivision 3A.1	2010 No. 129
r. 42ZCA.................	ad. 1999 No. 209
	rs. 2010 No. 129
Subdivision 3A.2
Subdivision 2.............. renumbered Subdivision 3A.2	2010 No. 129
r. 42ZCB.................	ad. 1999 No. 209
	rs. 2010 No. 129
r 42ZCC.................	ad No 209, 1999
	rs No 129, 2010
	am F2019L00109
r. 42ZCD.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCE.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCF.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCG.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCH.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCI.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCJ.................	ad. 1999 No. 209
	rs. 2010 No. 129
Subdivision 3A.3
Subdivision 3.............. renumbered Subdivision 3A.3	2010 No. 129
r. 42ZCK.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCL.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCM................	ad. 1999 No. 209
	rs. 2010 No. 129
r 42ZCN.................	ad No 209, 1999
	rs No 129, 2010
	am F2019L00109
r. 42ZCO.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCP.................	ad. 1999 No. 209
	rs. 2010 No. 129
Division 3B
Division 3B...............	ad. 2010 No. 129
Subdivision 3B.1
r. 42ZCQ.................	ad. 1999 No. 209
	rs. 2010 No. 129
Subdivision 3B.2
r. 42ZCR.................	ad. 1999 No. 209
	rs. 2010 No. 129
r 42ZCS.................	ad No 209, 1999
	rs No 129, 2010
	am F2019L00109
r. 42ZCT.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCU.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCV.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCW................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCX.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCY.................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCZ.................	ad. 1999 No. 209
	rs. 2010 No. 129
Subdivision 3B.3
r. 42ZCZA................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCZB................	ad. 1999 No. 209
	rs. 2010 No. 129
r. 42ZCZC................	ad. 2010 No. 129
r 42ZCZD................	ad No 129, 2010
	am F2019L00109
r. 42ZCZE................	ad. 2010 No. 129
r. 42ZCZF................	ad. 2010 No. 129
Division 3C
Division 3C...............	ad. 2010 No. 129
r. 42ZCZG................	ad. 2010 No. 129
r. 42ZCZH................	ad. 2010 No. 129
Division 3D
Division 3D...............	ad. 2010 No. 129
Subdivision 3D.1
r. 42ZCZI................	ad. 2010 No. 129
	am F2017L01561
Subdivision 3D.2
r. 42ZCZJ................	ad. 2010 No. 129
r. 42ZCZK................	ad. 2010 No. 129
r. 42ZCZL................	ad. 2010 No. 129
r. 42ZCZM...............	ad. 2010 No. 129
r. 42ZCZN................	ad. 2010 No. 129
r. 42ZCZO................	ad. 2010 No. 129
r. 42ZCZP................	ad. 2010 No. 129
	am F2017L01561
r. 42ZCZQ................	ad. 2010 No. 129
r. 42ZCZR................	ad. 2010 No. 129
r. 42ZCZS................	ad. 2010 No. 129
Subdivision 3D.3
r. 42ZCZT................	ad. 2010 No. 129
r. 42ZCZU................	ad. 2010 No. 129
r. 42ZCZV................	ad. 2010 No. 129
r. 42ZCZW...............	ad. 2010 No. 129
r. 42ZCZX................	ad. 2010 No. 129
Division 4................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZD..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZE..................	ad. 1999 No. 62
	am. 2000 No. 29
	rep. 2009 No. 374
r. 42ZF..................	ad. 1999 No. 62
	am. 2000 No. 29
	rep. 2009 No. 374
r. 42ZG..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZH..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZI..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZJ..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZK..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZL..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZM.................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZN..................	ad. 1999 No. 62
	am. 2000 No. 29
	rep. 2009 No. 374
r. 42ZO..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZP..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZQ..................	ad. 1999 No. 62
	am. 2000 No. 29
	rep. 2009 No. 374
r. 42ZR..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZS..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZT..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZU..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZV..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZW.................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZX..................	ad. 1999 No. 62
	am. 2000 No. 29
	rep. 2009 No. 374
r. 42ZY..................	ad. 1999 No. 62
	rep. 2009 No. 374
r. 42ZZ..................	ad. 1999 No. 62
	rep. 2009 No. 374
Division 5................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZA.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZB.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZC.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZD.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZE.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZF.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZG.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZH.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZI.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZJ.................	ad. 2000 No. 29
	am. 2003 No. 258
	rep. 2009 No. 374
r. 42ZZK.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZL.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZM................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZN.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZO.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZP.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZQ.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZR.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZS.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZT.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZU.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZV.................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZW................	ad. 2000 No. 29
	rep. 2009 No. 374
r. 42ZZX.................	ad. 2000 No. 29
	rep. 2009 No. 374
Part 7
Part 7 heading.............	rs. 1991 No. 84; 2009 No. 141
Division 1
Division 1................	ad. 2009 No. 141
Subdivision 1
Subdivision 1 heading........	rs. 2011 No. 30
r. 43AAA................	ad. 2009 No. 141
	am. 2011 No. 281
	rs No 75, 2015
Subdivision 2
Subdivision 2 heading........	rs F2016L00109
r 43AAAA................	ad F2016L00109
r. 43AAB................	ad. 2009 No. 141
	rs. 2011 No. 30
	rs No 75, 2015
	am F2016L00109
r 43AABA................	ad No 75, 2015
	rs F2016L00109
r 43AABB................	ad No 75, 2015
r. 43AAC................	ad. 2009 No. 141
	am. 2011 No. 30
	rs No 75, 2015
	am F2016L00109
r. 43AAD................	ad. 2009 No. 141
	rs No 75, 2015
r. 43AAE.................	ad. 2009 No. 141
	am. 2011 No. 30; 2012 No. 142
	rs No 75, 2015
	am F2016L00109
r. 43AAF.................	ad. 2009 No. 141
	am. 2012 No. 142
	rs No 75, 2015
r. 43AAG................	ad. 2009 No. 141
	am. 2011 No. 30
	rs No 75, 2015
Subdivision 2A
Subdivision 2A.............	ad F2016L00109
r 43AAGA................	ad F2016L00109
r 43AAGB................	ad F2016L00109
r 43AAGC................	ad F2016L00109
r 43AAGD................	ad F2016L00109
r 43AAGE................	ad F2016L00109
r 43AAGF................	ad F2016L00109
Subdivision 2B
Subdivision 2B heading.......	ad F2016L00109
r 43AAGG................	ad F2016L00109
	am F2021L00450
r. 43AAH................	ad. 2009 No. 141
	rs No 75, 2015
r. 43AAI.................	ad. 2009 No. 141
Subdivision 3
r 43AAJ.................	ad 2009 No 141
	am 2010 No 130; 2011 No 102; 2012 No 143; No 94, 2013; No 62, 2014; No 87, 2015; F2016L00667; F2017L00552; F2018L00759; F2019L00396; F2020L00720; F2021L00688; F2022L00600; F2023L00770; F2024L00689
Division 2
Division 2 heading..........	ad. 2009 No. 141
r 43....................	am No 151, 2003; No 30, 2011; No 214, 2015; F2018L00311
r 43A...................	ad No 222, 1994
	am No 234, 2002; No 102, 2011; No 214, 2015; F2018L00311; F2018L01612; F2019L01260
r. 43AA..................	ad. 1992 No. 19
	rs. 2011 No. 102
	am No 214, 2015
r. 43AB..................	ad. 2000 No. 267
	am No 214, 2015
r 43AC..................	ad No 214, 2015
	am F2017L00552; F2018L00759; F2019L00396; F2020L00720; F2021L00688; F2022L00600; F2023L00770; F2024L00689
r 43ACA.................	ad F2018L00311
	am F2018L00759; F2019L00396; F2020L00720; F2021L00688; F2022L00600; F2023L00770; F2024L00689
r 43AD..................	ad F2017L00853
r 43AE..................	ad F2018L00311
r 43AF..................	am F2019L00396
r 44AF..................	ad F2018L00311
r 45....................	am No 84, 1991; No 485, 1991; No 222, 1994; No 364, 1994; No 192, 1995; No 131, 1996; No 162, 1997; No 398, 1997; No 399, 1997; No  247, 1998; No 62, 1999; No 123, 2000; No 267, 2000; No 143, 2002; No 151, 2003; No 361, 2003; No 159, 2004; No  192, 2005; No 212, 2006; No 161, 2007; No 117, 2008; No 179, 2009; No  130, 2010; No 30, 2011; No 102, 2011; No 143, 2012; No 94, 2013; No 62, 2014; No 87, 2015; No 214, 2015; F2016L00667; F2017L00552; F2017L00853; F2018L00311; F2018L00759; F2018L01612; F2019L00396; F2019L01660; F2020L00720; F2020L01598; F2021L00688; F2022L00600; F2023L00770; F2024L00686; F2024L00689
r 45AA..................	ad 1995 No. 192
	am 2002 No. 234; 2011 No. 30; No 214, 2015; F2018L01434; F2020L00720
r. 45A...................	ad. 1991 No. 84
	am. 1997 No. 162; 2000 No. 267; 2001 No. 160; 2002 No. 234; 2003 No.  151; 2004 No. 159; 2005 No. 192; 2006 No. 212; 2007 No. 161; 2008 No.  117
	rs. 2009 No. 141
	am No 179, 2009; No. 130, 2010; 2012 No. 143; No. 94, 2013; No 62, 2014
	rep No 75, 2015
Part 7A..................	ad No 228, 2009
	rep F2018L00311
r 45B...................	ad No 228, 2009
	rep F2018L00311
Part 8
r 46AA..................	ad F2024L00686
r  46A...................	ad 1992 No 332
	rs 2009 No 140
	am No 26, 2010; F2016L00109; F2016L01614; F2017L00853; F2017L01561; F2023L00769
r 46B...................	ad F2024L00839
r. 46....................	am. 1991 No. 84; 1992 No. 332; 1997 No. 399; 1999 No. 62; 2002 No.  234; 2011 Nos. 30 and 102
r 47....................	rs No 485, 1991
	am No 332, 1992; No 400, 1997; No 48, 2000; No 343, 2001; No 345, 2002; No  78, 2004; No 228, 2009; F2016L00109; F2018L00311
r 47A...................	ad 1991 No 485
	am 2011 No 30; F2024L00839
r. 47AA..................	ad. 2000 No. 358
	rep. 2003 No. 361
	rs. 2002 No. 234; 2011 No. 30
r 47B...................	ad 1991 No 485
	am 1999 No 62
	rs 2000 No 358
	am 2002 No 234; 2011 No 30; F2016L00109; F2017L00853
r 47C...................	ad F2024L00839
r 48....................	am No 84, 1991; No 332, 1992; No 430, 1992; No 192, 1995; No 399, 1997; No 48, 2000; No  234, 2002; No 301, 2003; No 30, 2011; No 75, 2015; F2016L00109; F2017L00853; F2018L00311; F2020L00946; F2022L00243; F2022L01300; F2023L00769; F2023L01667; F2024L00686; F2024L01299; F2024L01673
Part 9
Part 9...................	ad. 2012 No. 251
Division 1
Division 1................	ad No 63, 2014
r 48A...................	ad No 63, 2014
r 48B...................	ad No 63, 2014
Division 2
Division 2 heading..........	ad No 63, 2014
r 49....................	ad 2012 No 251
	am No 63, 2014; F2023L01558
Division 3
Division 3................	ad No 214, 2015
r 50....................	ad No 214, 2015
Division 4
Division 4................	ad F2016L00109
r 51....................	ad F2016L00109
Division 5
Division 5................	ad F2017L00853
r 52....................	ad F2017L00853
r 53....................	ad F2017L00853
r 54....................	ad F2017L00853
r 55....................	ad F2017L00853
r 56....................	ad F2017L00853
Division 6
Division 6................	ad F2017L01561
r 57....................	ad F2017L01561
r 58....................	ad F2017L01561
r 59....................	ad F2017L01561
Division 7
Division 7................	ad F2018L00311
r 60....................	ad F2018L00311
r 61....................	ad F2018L00311
r 62....................	ad F2018L00311
Division 8
Division 8................	ad F2018L00516
r 63....................	ad F2018L00516
Division 9
Division 9................	ad F2018L00865
r 64....................	ad F2018L00865
	am F2018L01434
r 65....................	ad F2018L00865
	ed C83
r 66....................	ad F2018L00865
Division 10
Division 10...............	ad F2018L01434
r 67....................	ad F2018L01434
Division 11
Division 11...............	ad F2019L01260
r 68....................	ad F2019L01260
Division 12
Division 12...............	ad F2019L01660
Subdivision A
r 69....................	ad F2019L01660
Subdivision B
r 70....................	ad F2019L01660
	am F2020L00946
r 71....................	ad F2019L01660
	am F2020L00946
Subdivision C
r 72....................	ad F2019L01660
	am F2021L01474
Subdivision D
r 73....................	ad F2019L01660
Subdivision E
r 74....................	ad F2019L01660
Subdivision F
r 75....................	ad F2019L01660
Division 13
Division 13...............	ad F2020L00946
r 76....................	ad F2020L00946
r 77....................	ad F2020L00946
Division /span> 14...............	ad F2021L01032
	rep F2023L01667
r 78....................	ad F2021L01032
	rep F2023L01667
Division 15
Division 15...............	ad F2021L01390
r 79....................	ad F2021L01390
Division 16
Division 16...............	ad F2021L01474
r 80....................	ad F2021L01474
	rep F2023L01667
r 81....................	ad F2021L01474
r 82....................	ad F2021L01474
r 83....................	ad F2021L01474
Division 17
Division 17...............	ad F2021L01809
r 84....................	ad F2021L01809
r 85....................	ad F2021L01809
Division 18
Division 18...............	ad F2022L00243
r 86....................	ad F2022L00243
Division 19
Division 19...............	ad F2022L00243
r 87....................	ad F2022L00243
Division 20
Division 20...............	ad F2022L01687
r 88....................	ad F2022L01687
r 89....................	ad F2022L01687
Division 21
Division 21...............	ad F2023L00769
r 90....................	ad F2023L00769
Division 22
Division 22...............	ad F2023L01558
r 91....................	ad F2023L01558
r 92....................	ad F2023L01558
Division 23
Division 23...............	ad F2023L01667
r 93....................	ad F2023L01667
r 94....................	ad F2023L01667
r 95....................	ad F2023L01667
r 96....................	ad F2023L01667
	am F2024L00839
r 97....................	ad F2023L01667
	(3) exp 1 Dec 2024 (r 97(4))
Division 24
Division 24...............	ad F2024L00260
r 98....................	ad F2024L00260
Division 25
Division 25...............	ad F2024L00686
r 99....................	ad F2024L00686
r 100....................	ad F2024L00686
r 101....................	ad F2024L00686
r 102....................	ad F2024L00686
r 103....................	ad F2024L00686
Division 26
Division 26...............	ad F2024L00839
r 104....................	ad F2024L00839
r 105....................	ad F2024L00839
r 106....................	ad F2024L00839
r 107....................	ad F2024L00839
r 108....................	ad F2024L00839
	(2) exp end of 31 Dec 2024 (r 108(3))
Division 27
Division 27...............	ad F2024L01673
r 109....................	ad F2024L01673
r 110....................	ad F2024L01673
r 111....................	ad F2024L01673
Schedule 1
Schedule 1................	am 1992 No 89; 1992 No 332; 1994 No 150; 1994 No 364; 1995 No 208; 1997 No 398; 1999 No 324; 2001 No  159; 2003 No 258; 2006 No 122; 2012 No 142
Schedule 2
Schedule 2 heading..........	rs 2003 No 301
Schedule 2................	am 1994 No 150; 1995 No 208; 1997 No 398; 1999 No 324; 2000 No 48; 2001 No 159; 2001 No 252; 2002 No  234; 2006 No 122; F2016L01614; F2018L01434; F2021L01809
Schedule 3
Schedule 3 heading..........	rs F2018L00311
Schedule 3................	am 1991 No 84; 1991 No 485; 1992 No 19; 1992 No 89; 1992 No 370; 1994 No 150; 1994 No 364; 1995 No 208; 1997 No 398; 1997 No 399; 1999 No 62; 2002 No 84; 2002 No 114; 2002 No 143; 2002 No 234; 2002 No 315; 2004 No  78; 2010 No 26; No 213, 2015; F2018L01434; F2020L00946; F2023L01667
Schedule 4
Schedule 4 heading..........	am 1998 No 227
	rs 2002 No 234
Schedule 4................	am No 84, 1991; No 19, 1992; No 89, 1992; No 150, 1994; No 208, 1995; No 320, 1995; No 9, 1996; No 208, 1996; No 398, 1997; No 227, 1998; No 369, 1998; No 62, 1999; No 324, 1999; No  48, 2000; No 159, 2001; No 252, 2001; No 84, 2002; No 114, 2002; No 234, 2002; No 315, 2002; No 258, 2003; No 361, 2003; No 78, 2004; No 127, 2004; No  26, 2010; No 30, 2011; No 281, 2011; No 251, 2012; No 213, 2015; F2018L00311; F2018L00865; F2018L01434; F2019L00396; F2020L00946; F2020L01598; F2023L01558; F2023L01667; F2024L00686
Schedule 5
Schedule 5 heading..........	am. 2002 No. 234
	rs. 2011 No. 30
Schedule 5................	am. 1991 Nos. 84 and 485; 1992 Nos. 19, 89, 332 and 370; 1994 No. 150; 1995 No. 208; 1996 No. 9; 1997 Nos. 398 and 399; 1999 No.  62; 2000 Nos. 48 and 124; 2001 No. 159; 2002 No. 84; 2003 No. 258; 2010 No. 26; 2011 No.  30; 2012 No. 251; F2016L01652 (Sch 1 item 4 disallowed)
	ed C76
	am F2017L01561; F2018L00865; F2018L01434; F2018L01612
	ed C85
	am F2019L01660; F2021L01032; F2021L01474; F2022L00243; F2022L01687; F2023L01558; F2023L01667; F2024L00686; F2024L00839
Schedule 5A
Schedule 5A heading.........	am No 234, 2002
	rs No 30, 2011; No 251, 2012
Schedule 5A..............	ad No 84, 1991
	am No 89, 1992; No 150, 1994; No 364, 1994; No 33, 1995; No 208, 1995; No  9, 1996; No 399, 1997; No 62, 1999; No 358, 2000; No 159, 2001; No  343, 2001; No 84, 2002; No 345, 2002; No 111, 2003; No 78, 2004; No  26, 2010; No 30, 2011; No 214, 2015; F2016L01652; F2017L00853; F2017L01561; F2018L00311; F2018L00516; F2018L00865; F2019L01660; F2020L00720; F2020L00946; F2021L01474; F2021L01809; F2023L00769; F2023L01558; F2023L01667; F2024L00260; F2024L00686; Act No 50, 2024; F2024L00839; F2024L01673
Schedule 5B
Schedule 5B heading.........	rs. 2011 No. 30
Schedule 5B...............	ad 2003 No 111
	am 2010 No 266; 2011 No 30; F2017L00853
Schedule 6
Schedule 6................	am No 19, 1992; No 89, 1992; No 370, 1992; No 150; 1994; No 208, 1995; No 398, 1997; No 324, 1999; No  26, 2010
	rep F2020L00946
Schedule 7
Schedule 7 heading..........	am No 234, 2002
Schedule 7................	am No 84, 1991; No 19, 1992; No 89, 1992; No 370, 1992; No 150, 1994; No 208, 1995; No 398, 1997; No 227, 1998; No 324, 1999; No 124, 2000; No 159, 2001; No 26, 2010; No 251, 2012; F2018L00865; F2019L01660; F2020L00544; F2020L00946; F2023L01558; F2024L00839
Schedule 8
Schedule 8 heading..........	am. 2002 No. 234
Schedule 8................	am No 89, 1992; No 150, 1994; No 398, 1997; No 62, 1999; No 30, 2011; F2016L01652; F2017L01561; F2018L00865; F2020L00946
Schedule 9
Schedule 9 heading..........	rs 2011 No 30
Schedule 9................	am No 84, 1991; No 485, 1991; No 19, 1992, No 89, 1992; No 141, 1993; No 150, 1994; No 222, 1994; No 364, 1994; No 192, 1995; No 208, 1995; No 131, 1996; No 162, 1997; No 398, 1997; No 400, 1997; No 247, 1998; No 62, 1999; No 324, 1999; No 29, 2000; No 70, 2000; No 123, 2000; No 267, 2000; No 160; 2001; No 143, 2002; No 234, 2002; No 151, 2003; No 159, 2004; No 192, 2005; No 212, 2006; No 161, 2007; No 117, 2008; No 141, 2009; No 179, 2009; No 26, 2010; No 130, 2010; No 102, 2011; No 281, 2011; No 143, 2012; No 251, 2012; No 94, 2013; No 62, 2014; No 75, 2015; No 87, 2015; No 213, 2015; No 214, 2015; F2016L00109; F2016L00667; F2016L01614; F2017L00552; F2017L00853
	ed C77
	am F2017L01561; F2018L00311; F2018L00759; F2018L00865; F2018L01434; F2018L01612; F2019L00396
	ed C88
	am F2020L00720; F2020L00946; F2021L00688; F2022L00600; F2022L01687; F2023L00770; F2023L01558; F2024L00689
Schedule 9A
Schedule 9A..............	ad No 30, 2011
	am No 143, 2012; No 94, 2013; No 62, 2014; No 75, 2015; No 87, 2015; F2016L00109; F2016L00667; F2017L00552; F2017L00853; F2018L00311; F2018L00759; F2019L00396; F2020L00720
	ed C94
	am F2021L00688; F2022L00600; F2022L01300; F2023L00769; F2023L00770; F2024L00689
Schedule 10
Schedule 10 heading.........	rs. 1992 Nos. 332 and 370
	am. 1995 No. 208
	rs F2016L00109
Schedule 10...............	ad. 1992 No. 19
	am. 1992 No. 89; 1994 No. 150; 1995 No. 208
	rs. 1998 No. 227
	am No 62, 1999; No 29, 2000; No 78, 2004; No 26, 2010; No 102, 2011; F2016L00109; F2017L01561; F2020L00946
Schedule 11...............	ad. 1992 No. 89
	am. 1999 No. 324; 2002 No. 84
	rep. 2010 No. 26
Schedule 12
Schedule 12...............	ad. 1992 No. 430
	am. 1995 No. 208; 2001 No. 159; 2003 No. 151; 2011 No. 102
	rs F2019L01660
Schedule 13
Schedule 13...............	ad. 1995 No. 208
	am. 2001 No. 159; 2003 No. 151; 2011 No. 102
	rs F2019L01660
Schedule 14
Schedule 14 heading.........	am. 1999 No. 62
	rs. 2011 No. 102
Schedule 14...............	ad. 1997 No. 400
	rs. 1998 No. 227
	am F2018L00865
Schedule 15...............	ad. 2009 No. 228
	am F2016L00109
	rep F2018L00311
Schedule 16
Schedule 16...............	ad No 30, 2011
	rs F2018L00865
	am F2019L01660